T1	Value 8 26	18 years and older
T2	Person 3 6	Age
R1	Has_value Arg1:T2 Arg2:T1	
T3	Person 37 41	Male
T4	Condition 50 58	pregnant
T5	Negation 46 49	non
T6	Negation 60 63	non
T7	Condition 64 73	lactating
T8	Person 74 80	female
R2	Has_negation Arg1:T7 Arg2:T6	
R3	Has_negation Arg1:T4 Arg2:T5	
T9	Scope 46 73	non-pregnant, non-lactating
A1	Optional T8
R4	Has_scope Arg1:T8 Arg2:T9	
*	OR T8 T3
T14	Measurement 1417 1423	Weight
T15	Value 1425 1439	At least 60 kg
T16	Value 1425 1433;1441 1448	At least 132 lbs
R5	Subsumes Arg1:T15 Arg2:T16	
T17	Person 1454 1457	man
T18	Value 1425 1433;1462 1467	At least 48 kg
T19	Value 1425 1433;1469 1476	At least 106 lbs
R6	Subsumes Arg1:T18 Arg2:T19	
T20	Person 1482 1487	women
A2	Optional T20
A3	Optional T17
R7	Has_value Arg1:T17 Arg2:T15	
R8	Has_value Arg1:T20 Arg2:T18	
*	OR T20 T17
T21	Scope 1425 1487	At least 60 kg (132 lbs) for man and 48 kg (106 lbs) for women
R9	Has_scope Arg1:T14 Arg2:T21	
T22	Value 1492 1529	within 15% of Ideal Body Weight (IBW)
R10	Has_value Arg1:T14 Arg2:T22	
T10	Person 85 90	Women
T11	Condition 94 116	childbearing potential
T12	Value 127 135	negative
T13	Procedure 136 141;153 168	serum pregnancy tests
T23	Procedure 143 151	Beta HCG
R11	Subsumes Arg1:T13 Arg2:T23	
R12	Has_value Arg1:T13 Arg2:T12	
T24	Temporal 179 225	within 14 days prior to the start of the study
T25	Reference_point 203 225	the start of the study
R13	Has_index Arg1:T24 Arg2:T25	
R14	Has_temporal Arg1:T13 Arg2:T24	
T26	Temporal 230 278	on the evening prior to each dose administration
T27	Reference_point 254 278	each dose administration
R15	Has_index Arg1:T26 Arg2:T27	
R16	Has_temporal Arg1:T13 Arg2:T26	
T28	Scope 85 116	Women of childbearing potential
A4	Optional T28
T29	Scope 127 278	negative serum (Beta HCG) pregnancy tests performed within 14 days prior to the start of the study and on the evening prior to each dose administration
R17	Has_scope Arg1:T28 Arg2:T29	
T30	Person 515 520	Women
T31	Condition 524 546	childbearing potential
T32	Procedure 561 571	abstinence
T33	Qualifier 587 602	acceptable form
T34	Procedure 606 619	contraception
T35	Temporal 620 656	throughout the duration of the study
R18	Has_qualifier Arg1:T34 Arg2:T33	
*	OR T34 T32
T36	Scope 561 619	abstinence or be using an acceptable form of contraception
R19	Has_temporal Arg1:T36 Arg2:T35	
T37	Scope 515 546	Women of childbearing potential
A5	Optional T37
R20	Has_scope Arg1:T37 Arg2:T36	
T38	Device 720 739	intrauterine device
T39	Temporal 749 802	for at least 3 months prior to the start of the study
T40	Reference_point 780 802	the start of the study
R21	Has_index Arg1:T39 Arg2:T40	
T41	Temporal 817 849	in place during the study period
T42	Reference_point 833 849	the study period
R22	Has_index Arg1:T41 Arg2:T42	
R23	Has_temporal Arg1:T38 Arg2:T39	
R24	Has_temporal Arg1:T38 Arg2:T41	
T43	Procedure 858 873	barrier methods
T44	Drug 915 932	spermicidal agent
T45	Scope 858 932	barrier methods containing or used in conjunction with a spermicidal agent
T46	Condition 941 955	postmenopausal
T47	Temporal 1011 1028	at least one year
T48	Condition 1032 1050	surgical sterility
R25	Has_temporal Arg1:T46 Arg2:T47	
T49	Procedure 1052 1066	tubal ligation
T50	Procedure 1068 1080	oophorectomy
T51	Procedure 1084 1096	hysterectomy
*	OR T50 T51 T49
T52	Scope 1052 1096	tubal ligation, oophorectomy or hysterectomy
R26	Subsumes Arg1:T48 Arg2:T52	
T53	Scope 1032 1097	surgical sterility (tubal ligation, oophorectomy or hysterectomy)
*	OR T46 T53 T45 T38
T54	Person 1202 1207	women
T55	Condition 1211 1233	childbearing potential
T56	Procedure 1245 1298	spermicide containing barrier method of contraception
T57	Multiplier 1299 1313	in addition to
T58	Temporal 1320 1327	current
T59	Device 1328 1348	contraceptive device
R27	Has_temporal Arg1:T59 Arg2:T58	
R28	Has_multiplier Arg1:T56 Arg2:T57	
T60	Scope 1202 1233	women of childbearing potential
A6	Optional T60
T61	Scope 1245 1348	spermicide containing barrier method of contraception in addition to their current contraceptive device
R29	Has_scope Arg1:T60 Arg2:T61	
T62	Temporal 1103 1133	During the course of the study
R30	Has_temporal Arg1:T61 Arg2:T62	
T63	Condition 1735 1741	normal
T64	Condition 1746 1753	healthy
T65	Procedure 1763 1791	pre-study medical evaluation
T66	Scope 1735 1753	normal and healthy
R31	Has_scope Arg1:T65 Arg2:T66	
T67	Procedure 1793 1813	physical examination
T68	Procedure 1815 1836	laboratory evaluation
T69	Procedure 1838 1849	12-lead ECG
T70	Procedure 1851 1862;1879 1884	hepatitis B tests
T71	Procedure 1867 1884	hepatitis C tests
T72	Procedure 1886 1894	HIV test
T73	Procedure 1900 1917	urine drug screen
T74	Qualifier 1928 1939	amphetamine
T75	Qualifier 1941 1953	barbiturates
T76	Qualifier 1955 1969	benzodiazepine
T77	Qualifier 1971 1982	cannabinoid
T78	Qualifier 1984 1991	cocaine
T79	Qualifier 1993 2000	opiates
T80	Qualifier 2002 2015	phencyclidine
T81	Qualifier 2021 2030	methadone
T82	Scope 1928 2030	amphetamine, barbiturates, benzodiazepine, cannabinoid, cocaine, opiates, phencyclidine, and methadone
R32	Has_scope Arg1:T73 Arg2:T82	
T83	Scope 1793 2030	physical examination, laboratory evaluation, 12-lead ECG, hepatitis B and hepatitis C tests, HIV test, and urine drug screen including amphetamine, barbiturates, benzodiazepine, cannabinoid, cocaine, opiates, phencyclidine, and methadone
T84	Temporal 2042 2096	within 14 days of the initial dose of study medication
T85	Reference_point 2060 2096	the initial dose of study medication
R33	Has_index Arg1:T84 Arg2:T85	
R34	Subsumes Arg1:T65 Arg2:T83	
R35	Has_temporal Arg1:T65 Arg2:T84	
